High Throughput Production of mRNA

Moderna Therapeutics (NASDAQ: MRNA) is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Moderna’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immunooncology, rare diseases and cardiovascular diseases, independently and with strategic collaborators.

[psdonover]

Unprecedented economy of scale!! Tight presentation! Thanks!

[bardacha]

Very interesting presentation ! Many thanks

[nickvoutsas]

I am impressed at how integrated there chain of technology is. This allows for quick innovation or Tailored cures focused on Cancer treatments .

[leaprotein]

20 min useless info for preclinical mRNA researchers. No!